tiprankstipranks
Trending News
More News >
Medexus Pharmaceuticals (TSE:MDP)
:MDP
Canadian Market

Medexus Pharmaceuticals Inc (MDP) Ratios

Compare
59 Followers

Medexus Pharmaceuticals Inc Ratios

TSE:MDP's free cash flow for Q3 2024 was $0.51. For the 2024 fiscal year, TSE:MDP's free cash flow was decreased by $ and operating cash flow was $0.10. See a summary of the company’s cash flow.
Ratios
TTM
Mar 24Mar 23Mar 22Mar 21
Liquidity Ratios
Current Ratio
0.87 0.87 1.02 1.47 1.17
Quick Ratio
0.60 0.60 0.58 1.10 0.76
Cash Ratio
0.16 0.16 0.21 0.47 0.15
Solvency Ratio
0.07 0.07 0.04 -0.16 <0.01
Operating Cash Flow Ratio
-0.02 -0.02 -0.02 0.13 -0.05
Short-Term Operating Cash Flow Coverage
-0.03 -0.03 -0.08 0.48 -0.16
Net Current Asset Value
$ -22.08M$ -65.91M$ -72.32M$ -71.92M$ -58.49M
Leverage Ratios
Debt-to-Assets Ratio
0.43 0.43 0.39 0.30 0.32
Debt-to-Equity Ratio
3.12 3.12 3.08 2.49 1.60
Debt-to-Capital Ratio
0.76 0.76 0.76 0.71 0.62
Long-Term Debt-to-Capital Ratio
0.55 0.55 0.69 0.66 0.54
Financial Leverage Ratio
7.19 7.19 7.83 8.24 5.06
Debt Service Coverage Ratio
0.37 0.37 0.59 -1.00 0.47
Interest Coverage Ratio
0.56 0.56 -1.23 -0.14 -0.84
Debt to Market Cap
2.97 2.97 1.12 0.47 1.08
Interest Debt Per Share
4.19 4.19 3.45 3.60 3.15
Net Debt to EBITDA
-31.47 3.89 2.96 -1.11 4.77
Profitability Margins
Gross Profit Margin
55.54%55.54%49.45%52.73%56.15%
EBIT Margin
7.92%7.92%10.96%-27.22%2.52%
EBITDA Margin
13.55%13.55%19.77%-29.63%13.42%
Operating Profit Margin
7.04%7.04%-19.55%-1.73%-10.32%
Pretax Profit Margin
-4.66%-4.66%-4.98%-39.54%-9.89%
Net Profit Margin
1.13%1.13%-3.75%-35.48%-8.39%
Continuous Operations Profit Margin
1.13%1.13%-3.75%-35.48%-11.89%
Net Income Per EBT
-24.22%-24.22%75.37%89.72%84.76%
EBT Per EBIT
-66.21%-66.21%25.47%2289.32%95.84%
Return on Assets (ROA)
-5.75%0.76%-2.07%-19.03%-3.58%
Return on Equity (ROE)
-17.53%5.44%-16.18%-156.87%-18.11%
Return on Capital Employed (ROCE)
-5.90%9.78%-16.46%-1.27%-6.11%
Return on Invested Capital (ROIC)
-6.11%-1.53%-10.65%-1.04%-4.64%
Return on Tangible Assets
-13.48%1.51%-5.54%-45.96%-10.16%
Earnings Yield
-11.20%5.17%-5.90%-29.58%-12.25%
Efficiency Ratios
Receivables Turnover
4.83 4.83 5.32 4.23 3.50
Payables Turnover
4.73 4.73 3.22 2.53 2.58
Inventory Turnover
2.10 2.10 1.82 2.57 1.63
Fixed Asset Turnover
120.24 120.24 62.82 100.20 47.70
Asset Turnover
0.67 0.67 0.55 0.54 0.43
Working Capital Turnover Ratio
-22.70 -22.70 7.81 6.50 3.46
Cash Conversion Cycle
-94.74 171.95 156.15 84.45 186.44
Days of Sales Outstanding
107.01 75.57 68.56 86.27 104.16
Days of Inventory Outstanding
149.02 173.53 200.99 142.17 223.67
Days of Payables Outstanding
350.78 77.15 113.40 143.99 141.39
Operating Cycle
256.04 249.10 269.55 228.45 327.82
Cash Flow Ratios
Operating Cash Flow Per Share
-0.07 -0.07 -0.06 0.33 -0.11
Free Cash Flow Per Share
-0.09 -0.09 -0.46 -0.38 -0.17
CapEx Per Share
0.02 0.02 0.40 0.71 0.06
Free Cash Flow to Operating Cash Flow
1.25 1.25 7.54 -1.13 1.52
Dividend Paid and CapEx Coverage Ratio
-3.99 -3.99 -0.15 0.47 -1.93
Capital Expenditure Coverage Ratio
-3.99 -3.99 -0.15 0.47 -1.93
Operating Cash Flow Coverage Ratio
-0.02 -0.02 -0.02 0.11 -0.04
Operating Cash Flow to Sales Ratio
-0.01 -0.01 -0.02 0.06 -0.03
Free Cash Flow Yield
-5.43%-7.64%-18.22%-5.98%-6.86%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
19.36 19.36 -16.96 -3.38 -8.16
Price-to-Sales (P/S) Ratio
0.22 0.22 0.64 1.20 0.68
Price-to-Book (P/B) Ratio
1.05 1.05 2.74 5.30 1.48
Price-to-Free Cash Flow (P/FCF) Ratio
-13.09 -13.09 -5.49 -16.71 -14.57
Price-to-Operating Cash Flow Ratio
-16.37 -16.37 -41.37 18.97 -22.13
Price-to-Earnings Growth (PEG) Ratio
-0.14 -0.14 0.18 >-0.01 0.22
Price-to-Fair Value
1.05 1.05 2.74 5.30 1.48
Enterprise Value Multiple
5.51 5.51 6.18 -5.16 9.88
Enterprise Value
38.60M 80.65M 93.66M 121.72M 69.48M
EV to EBITDA
242.76 5.51 6.18 -5.16 9.88
EV to Sales
1.52 0.75 1.22 1.53 1.33
EV to Free Cash Flow
-16.29 -44.65 -10.53 -21.29 -28.19
EV to Operating Cash Flow
-19.90 -55.85 -79.38 24.16 -42.82
Tangible Book Value Per Share
-2.91 -2.91 -3.57 -4.54 -3.85
Shareholders’ Equity Per Share
1.12 1.12 0.91 1.19 1.69
Tax and Other Ratios
Effective Tax Rate
1.24 1.24 0.25 0.10 0.15
Revenue Per Share
5.41 5.41 3.94 5.24 3.65
Net Income Per Share
0.06 0.06 -0.15 -1.86 -0.31
Tax Burden
1.04 -0.24 0.75 0.90 0.85
Interest Burden
2.84 -0.59 -0.45 1.45 -3.92
Research & Development to Revenue
0.00 0.03 0.08 0.06 0.02
SG&A to Revenue
0.22 0.34 0.45 0.24 0.22
Stock-Based Compensation to Revenue
0.02 0.01 0.02 0.02 0.03
Income Quality
0.40 -1.18 0.41 -0.18 0.37
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis